Prelude Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-66,445
| Closed | -$2.55M | – | 1366 |
|
|
2023
Q2 | $2.55M | Buy |
+66,445
| New | +$2.55M | 0.17% | 132 |
|
|
2023
Q1 | – | Sell |
-10,502
| Closed | -$275K | – | 1488 |
|
|
2022
Q4 | $275K | Buy |
+10,502
| New | +$275K | 0.01% | 714 |
|
|
2018
Q1 | – | Sell |
-18
| Closed | -$1K | – | 1620 |
|
|
2017
Q4 | $1K | Sell |
18
-1
| -5% | -$56 | ﹤0.01% | 1172 |
|
|
2017
Q3 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 1439 |
|
|
2015
Q3 | – | Sell |
-140
| Closed | -$21K | – | 1788 |
|
|
2015
Q2 | $21K | Buy |
+140
| New | +$21K | ﹤0.01% | 1264 |
|